Growth Metrics

Codexis (CDXS) Work In Process (2011 - 2026)

Codexis' quarterly Work In Process came in at $441000.0 in Q1 2026, down 75.34% year-on-year from $1.8 million in Q1 2025, and down 10.37% quarter-over-quarter from $492000.0 in Q4 2025.

Codexis has reported Work In Process for 16 years, with the latest figure at $441000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Work In Process fell 75.34% year-over-year to $441000.0; the trailing twelve-month figure through Mar 2026 stood at $441000.0 (down 75.34% YoY), and the FY2025 full-year result was $492000.0, down 88.75% from the prior year.
  • Work In Process for Q1 2026 stood at $441000.0, down from $492000.0 in the prior quarter.
  • The five-year high for Work In Process was $11.3 million in Q2 2022, with the low at $441000.0 in Q1 2026.
  • Average Work In Process over 5 years is $3.3 million, with a median of $2.2 million recorded in 2023.
  • Year-over-year, Work In Process soared 436.81% in 2024 and plunged 88.75% in 2025.
  • Tracing CDXS's Work In Process over 5 years: stood at $2.1 million in 2022, then sank by 61.48% to $815000.0 in 2023, then soared by 436.81% to $4.4 million in 2024, then sank by 88.75% to $492000.0 in 2025, then declined by 10.37% to $441000.0 in 2026.
  • The last three Work In Process figures came in at $441000.0 (Q1 2026), $492000.0 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Codexis 251.43 Mn 186.29 Mn 13.18 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 441,000.00
Dec 31, 2025 492,000.00
Sep 30, 2025 2.13 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 1.79 Mn
Dec 31, 2024 4.38 Mn
Sep 30, 2024 3.42 Mn
Jun 30, 2024 3.21 Mn
Mar 31, 2024 2.57 Mn
Dec 31, 2023 815,000.00
Sep 30, 2023 1.94 Mn
Jun 30, 2023 2.25 Mn
Mar 31, 2023 2.45 Mn
Dec 31, 2022 2.12 Mn
Sep 30, 2022 5.87 Mn
Jun 30, 2022 11.29 Mn
Mar 31, 2022 9.75 Mn
Dec 31, 2021 4.56 Mn
Sep 30, 2021 12.70 Mn
Jun 30, 2021 4.53 Mn
Mar 31, 2021 5.14 Mn
Dec 31, 2020 4.53 Mn
Sep 30, 2020 975,000.00
Mar 31, 2020 619,000.00
Dec 31, 2019 1.03 Mn
Sep 30, 2019 52,000.00
Jun 30, 2019 157,000.00
Mar 31, 2019 158,000.00
Dec 31, 2018 47,000.00
Sep 30, 2018 79,000.00
Jun 30, 2018 62,000.00
Mar 31, 2018 123,000.00
Dec 31, 2017 53,000.00
Sep 30, 2017 110,000.00
Jun 30, 2017 227,000.00
Mar 31, 2017 163,000.00
Dec 31, 2016 59,000.00
Sep 30, 2016 128,000.00
Jun 30, 2016 153,000.00
Mar 31, 2016 37,000.00
Sep 30, 2015 11,000.00
Jun 30, 2015 122,000.00
Mar 31, 2015 20,000.00
Dec 31, 2014 65,000.00
Sep 30, 2014 17,000.00
Jun 30, 2014 229,000.00
Mar 31, 2014 109,000.00
Dec 31, 2013 31,000.00
Sep 30, 2013 235,000.00
Jun 30, 2013 155,000.00
Mar 31, 2013 112,000.00
Dec 31, 2012 52,000.00
Jun 30, 2012 48,000.00
Dec 31, 2011 54,000.00